BioFreedom US IDE Feasibility Trial
NCT02131142
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
UNKNOWN
Status
72
Enrollment
INDUSTRY
Sponsor class
Conditions
Ischemic Heart Disease
Stable Angina
Unstable Angina
Silent Ischemia
Interventions
DEVICE:
BioFreedom drug coated coronary stent
Sponsor
Biosensors Europe SA